Dechra announced earlier today that it has received approval from the FDA for its pergolide tablets (Zygolide; Dechra) to ...

The correct veterinary term for Cushing’s disease in horses is Pituitary pars intermedia dysfunction (PPID). This describes the region of the pituitary gland — the pars intermedia — which is ...

The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

Machines which more accurately detect the concentration of certain substances in blood samples have been purchased by equine vet practice VetPartners to benefit horses with Cushing’s disease.

Horse Owners: New Website Includes Science-Based Resources On Equine Wellness originally appeared on Paulick Report. Horse owners have a new, science-based resource for expert information on equine ...